Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
TheInternational journal of molecular sciences · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Bärbel KieningerDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.ORCID 0000-0002-2918-6684
Gabriel E WagnerDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-5704-3955
Anca RathDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.ORCID 0009-0003-1992-1897
Anja EichnerDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.
Jürgen FritschDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.ORCID 0000-0001-6909-6096
Aila Caplunik-PratschDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.ORCID 0009-0001-5287-0492
Jasmine AlikhaniDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.
Parham Heydarzadeh-GhamsaryDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.
Adriana Cabal-RoselAustrian Agency for Health and Food Safety (AGES), Institute of Medical Microbiology and Hygiene, Vienna, Austria.
Werner RuppitschAustrian Agency for Health and Food Safety (AGES), Institute of Medical Microbiology and Hygiene, Vienna, Austria.ORCID 0000-0001-9940-3333
Dag HarmsenDepartment of Periodontology and Operative Dentistry, University Hospital Münster, Münster, Germany.
Mohammed R AbdullaFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Lena UlmFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-3388-8785
Karsten BeckerFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-6391-1341
Wulf Schneider-BrachertDepartment of Infection Prevention and Infectious Diseases, University Medical Center Regensburg, Regensburg, Germany.ORCID 0000-0002-2707-2923
Christian KohlerFriedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0003-3921-6776
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
IMPORTANCE: Accurate identification and high-resolution typing of multidrug-resistant bacteria are essential for understanding their transmission dynamics in hospitals, particularly in light of the global spread of resistant strains and the role of environmental reservoirs. The newly developed cgMLST schemes presented here provide standardized, portable tools for both local and global scientific and clinical communities to conduct fine-scale genomic epidemiology across four
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Development and validation of a core genome multilocus sequence typing scheme for · full record | OpenQuestion